Suppr超能文献

一项多中心回顾性队列研究:估算 COVID-19 住院患者在一年以上时间内的门诊 SARS-CoV-2 再感染和复发率及其相关因素。

Estimation of outpatient SARS-CoV-2 reinfection and recurrence rates and associated factors among COVID-19 hospitalized patients over one-year old: a multicenter retrospective cohort study.

机构信息

Cardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khorramabad, Iran.

Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

BMC Infect Dis. 2024 Sep 18;24(1):999. doi: 10.1186/s12879-024-09872-2.

Abstract

INTRODUCTION

Reinfection with SARS-Cov-2 after recovery can occur that most of them don't require hospitalization. The aim of this study is estimation of out-patient COVID-19 reinfection and recurrence rates and its associated factors among Iranian patients with history of confirmed SARS-Cov-2 infection and hospitalization.

METHODS

This study is a retrospective cohort conducted from May 2021 to May 2022 in Iran. The national Medical Care Monitoring Center (MCMC) database, obtained from the Ministry of Health and Medical Education, includes all information about confirmed COVID-19 patients who are hospitalized and diagnosed during the pandemic. Using probability proportional to size sampling from 31 provinces, 1,532 patients over one years of age with a history of hospitalization in the MCMC data are randomly selected. After that, interviews by phone are performed with all of the selected patients using a researcher-made questionnaire about the occurrence of overall reinfection without considering the time of infection occurrence, reinfection occurring at least 90 days after the discharge and recurrence (occurring within 90 days after discharge). Univariate and multivariable Cox regression analyses are performed to assess the factors associated with each index. All of the analyses are performed using Stata software version 16.

RESULTS

In general, 1,532 phone calls are made, out of which 1,095 individuals are willing to participate in the study (response rate ≃ 71%). After assessing the 1,095  patients with a positive history of COVID-19, the rates of non-hospitalized overall SARS-Cov-2 reinfection, reinfection and recurrence are 122.64, 114.09, and 8.55 per 1,000 person-years, respectively. The age range of 19-64 years (aHR:3.93, 95%CI : 1.24-12.41) and COVID-19-related healthcare worker (aHR: 3.67, 95%CI: 1.77-7.61) are identified as risk factors for reinfection, while having comorbidity, being fully vaccinated, and having a partial pressure of oxygen (PaO2) ≥ 93 mmHg during the initial infection are identified as factors that reduce the risk of non-hospitalized reinfection.

CONCLUSION

Reinfection due to COVID-19 is possible because of the weakened immune system for various reasons and the mutation of the virus. Vaccination, timely boosters, and adherence to preventive measures can help mitigate this risk.

摘要

简介

在康复后,SARS-CoV-2 的再次感染是可能发生的,其中大多数不需要住院治疗。本研究的目的是评估伊朗有确诊 SARS-CoV-2 感染和住院史的患者的门诊 COVID-19 再感染和复发率及其相关因素。

方法

本研究是 2021 年 5 月至 2022 年 5 月在伊朗进行的回顾性队列研究。国家医疗保健监测中心(MCMC)数据库来自卫生部和教育部,其中包含在大流行期间住院和诊断的所有确诊 COVID-19 患者的信息。采用比例概率抽样方法,从 31 个省份中随机抽取 1532 名年龄在 1 岁以上、MCMC 数据中有住院史的患者。之后,使用研究人员制作的问卷对所有选定的患者进行电话访谈,内容涉及整体再感染(不考虑感染发生时间)、出院后至少 90 天发生的再感染和复发(出院后 90 天内发生)。采用单变量和多变量 Cox 回归分析评估与每个指标相关的因素。所有分析均使用 Stata 软件版本 16 进行。

结果

一般来说,共拨打了 1532 个电话,其中 1095 人愿意参与研究(应答率≈71%)。在评估了 1095 名有 COVID-19 阳性史的患者后,非住院 SARS-CoV-2 整体再感染、再感染和复发的发生率分别为 122.64、114.09 和 8.55/1000 人年。19-64 岁年龄组(aHR:3.93,95%CI:1.24-12.41)和与 COVID-19 相关的医护人员(aHR:3.67,95%CI:1.77-7.61)被确定为再感染的危险因素,而合并症、完全接种疫苗以及初次感染时的血氧分压(PaO2)≥93mmHg 被确定为降低非住院再感染风险的因素。

结论

由于各种原因导致的免疫系统减弱和病毒突变,COVID-19 可能会再次感染。接种疫苗、及时加强针和遵守预防措施可以帮助降低这种风险。

相似文献

2
3
Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients.
Clin Microbiol Infect. 2021 Dec;27(12):1860.e7-1860.e10. doi: 10.1016/j.cmi.2021.07.030. Epub 2021 Aug 19.
6
Effectiveness Associated With Vaccination After COVID-19 Recovery in Preventing Reinfection.
JAMA Netw Open. 2022 Jul 1;5(7):e2223917. doi: 10.1001/jamanetworkopen.2022.23917.
7
Association of SARS-CoV-2 Seropositivity and Symptomatic Reinfection in Children in Nicaragua.
JAMA Netw Open. 2022 Jun 1;5(6):e2218794. doi: 10.1001/jamanetworkopen.2022.18794.
9
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
PLoS Med. 2022 Nov 22;19(11):e1004037. doi: 10.1371/journal.pmed.1004037. eCollection 2022 Nov.

引用本文的文献

2
Role of COVID-19 infection status on the prediction of future infection: Immunity or susceptibility.
PLoS One. 2025 Mar 26;20(3):e0317959. doi: 10.1371/journal.pone.0317959. eCollection 2025.

本文引用的文献

1
2
COVID-19 Reinfection Rate and Related Risk Factors in Fars Province, Iran: A Retrospective Cohort Study.
Iran J Med Sci. 2023 May;48(3):302-312. doi: 10.30476/IJMS.2022.94615.2598.
3
Characteristics and clinical outcomes of patients with COVID-19 recurrent infection during the omicron variant predominance.
Eur J Intern Med. 2023 Aug;114:131-134. doi: 10.1016/j.ejim.2023.05.017. Epub 2023 May 15.
5
Nationwide study of rates of reinfection with SARS-CoV-2 among adults in Kuwait.
East Mediterr Health J. 2023 Feb 26;29(2):146-150. doi: 10.26719/emhj.23.015.
6
Risk of reinfection and disease after SARS-CoV-2 primary infection: Meta-analysis.
Eur J Clin Invest. 2022 Oct;52(10):e13845. doi: 10.1111/eci.13845. Epub 2022 Aug 8.
7
Reinfection with SARS-CoV-2 in general population, South Korea; nationwide retrospective cohort study.
J Med Virol. 2022 Nov;94(11):5589-5592. doi: 10.1002/jmv.28026. Epub 2022 Aug 2.
8
High Number and Specific Comorbidities Could Impact the Immune Response in COVID-19 Patients.
Front Immunol. 2022 Jul 5;13:899930. doi: 10.3389/fimmu.2022.899930. eCollection 2022.
9
Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: A population-level observational study.
Lancet Reg Health Eur. 2022 Sep;20:100453. doi: 10.1016/j.lanepe.2022.100453. Epub 2022 Jul 1.
10
COVID-19 mortality and its predictors in the elderly: A systematic review.
Health Sci Rep. 2022 May 23;5(3):e657. doi: 10.1002/hsr2.657. eCollection 2022 May.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验